PARP Inhibitors Could Enhance Immunotherapy Response in Mesothelioma
A new study suggests that drugs known as PARP inhibitors may enhance immunotherapy response in mesothelioma patients. According to a…
Obtain the latest insights on mesothelioma clinical trials in Europe. Should you be doing chemotherapy or holistic instead? Learn More